FilingIndex
8-KThe WireStrategic

Results of Operations

Filed May 7, 2026 · 1mo ago · Accession 0001628280-26-032093

Plain English

Ginkgo Bioworks Holdings, Inc. reported its first quarter 2026 financial results, which included a decrease in revenue and a net loss from continuing operations. The company also announced the completion of its Biosecurity business divestiture.

Read the original on SEC.gov ↗
Filing details
Ticker
DNA
CIK
1830214
Form type
8-K
Filing date
May 7, 2026
Report date
May 7, 2026
Document
dna-20260507.htm
Size
361 KB